Zerin Hyder
Overview
Explore the profile of Zerin Hyder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
335
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Evans D, Phillips K, Milne R, Fruscio R, Cybulski C, Gronwald J, et al.
Br J Cancer
. 2023 Jan;
128(4):703.
PMID: 36639528
No abstract available.
2.
Smedley D, Smith K, Martin A, Thomas E, McDonagh E, Cipriani V, et al.
N Engl J Med
. 2021 Nov;
385(20):1868-1880.
PMID: 34758253
Background: The U.K. 100,000 Genomes Project is in the process of investigating the role of genome sequencing in patients with undiagnosed rare diseases after usual care and the alignment of...
3.
Pagnamenta A, Jackson A, Perveen R, Beaman G, Petts G, Gupta A, et al.
Clin Genet
. 2021 Oct;
101(1):127-133.
PMID: 34612517
Only two families have been reported with biallelic TMEM260 variants segregating with structural heart defects and renal anomalies syndrome (SHDRA). With a combination of genome, exome sequencing and RNA studies,...
4.
Hyder Z, Calpena E, Pei Y, Tooze R, Brittain H, Twigg S, et al.
Genet Med
. 2021 Aug;
23(12):2360-2368.
PMID: 34429528
Purpose: Genome sequencing (GS) for diagnosis of rare genetic disease is being introduced into the clinic, but the complexity of the data poses challenges for developing pipelines with high diagnostic...
5.
Radley J, Connolly M, Sabir A, Kanani F, Carley H, Jones R, et al.
Clin Genet
. 2021 May;
100(3):292-297.
PMID: 33993487
The congenital imprinting disorder, Beckwith-Wiedemann syndrome (BWS) is associated with variable clinical features including hemihypertrophy/lateralised overgrowth (LO) and embryonal tumour predisposition. BWS-associated (epi)genetic alterations occur in a subset of patients...
6.
Hyder Z, Van Paesschen W, Sabir A, Sansbury F, Burke K, Khan N, et al.
Eur J Hum Genet
. 2021 Feb;
29(9):1377-1383.
PMID: 33603162
ERBB4 encodes the tyrosine kinase receptor HER4, a critical regulator of normal cell function and neurodevelopmental processes in the brain. One of the key ligands of HER4 is neureglin-1 (NRG1),...
7.
Evans D, Phillips K, Milne R, Fruscio R, Cybulski C, Gronwald J, et al.
Br J Cancer
. 2021 Feb;
124(9):1524-1532.
PMID: 33597716
Background: The impact of various breast-cancer treatments on patients with a BRCA2 mutation has not been studied. We sought to estimate the impact of bilateral oophorectomy and other treatments on...
8.
Hyder Z, Fairclough A, Groom M, Getty J, Alexander E, van Veen E, et al.
J Med Genet
. 2020 Sep;
58(9):581-585.
PMID: 32917767
Background: Nephroblastomatosis is a recognised precursor for the development of Wilms tumour (WT), the most common childhood renal tumour. While the majority of WT is sporadic in origin, germline intragenic...
9.
Hyder Z, Harkness E, Woodward E, Bowers N, Pereira M, Wallace A, et al.
Cancers (Basel)
. 2020 Feb;
12(2).
PMID: 32045981
Early age at diagnosis of breast cancer is a known risk factor for hereditary predisposition and some studies show a high risk of contralateral breast cancer in carriers diagnosed at...
10.
Hyder Z, Fairclough A, Douzgou S
Clin Dysmorphol
. 2019 May;
28(3):131-136.
PMID: 31045593
Intermediate interstitial deletions of the long arm of chromosome 1 are typically associated with developmental delay and dysmorphic features. We describe the case of a 31-year-old male with intellectual disability,...